Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Drug: Palbociclib;   Drug: Carboplatin
Sponsor:   University of Michigan Cancer Center
Not yet recruiting - verified June 2017

http://ift.tt/2sTKpsX